AzTrials
AzTrials

ADHDCLS-RNCT05713331

Web-based Professional Development for SMHPs in Evidence-Based Practices for Attention and Behavior Challenges

A study testing CLS-R in people with ADHD, run by University of California, San Francisco at 2 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study develops a web-based PD (CLS-R) to provide SSWs with remote training in EBPs for attention and behavior problems. CLS-R is designed to be usable, feasible, portable, accessible, and acceptable - ingredients which have been identified as necessary for the sustainability of school-based programs. Read more about this study

Who is it for?
Ages 7 to 11 yearsHealthy volunteers can take part
Conditions the study is for
ADHD
What is being tested?
CLS-R
Could I receive a placebo?
No, everyone receives an active treatment
How many people
79 participants
Where
2 sitesUnited States
Study dates
1 Sep 2017to 30 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children ages 7-11, 2nd-5th grades
  • Presence of academic and social problems related to inattention and/or hyperactivity/impulsivity (as judged by school SSW)
  • Six or more inattention symptoms and/or six or more hyperactive/impulsive symptoms endorsed across parent and teacher rating scales (using an either-or algorithm, such that a symptom is counted as being present if either parent or teacher endorses it as occurring 'often' or 'very often')
  • Functional impairment reported by either parent or teacher on the IRS (score of 3 or greater)
  • Caretaker available and consents to participate in treatment
  • Currently attending a participating school full-time

Who cannot join

  • Presence of conditions that are incompatible with this study's treatment:
  • severe visual or hearing impairment,
  • severe language delay,
  • psychosis,
  • pervasive developmental disorder
  • Parent or child does not read or speak English or does not read or speak Spanish for our Spanish language implementation of CLS (inability to complete assessment measures or participate in group treatments).
Show all 10Show fewer
  • Child is in an all-day special education classroom (children in these classrooms are frequently receiving intensive behavior modification programs such that the intervention would be expected to require modification for use in these settings)
  • Children taking psychotropic medication for any reason other than to treat ADHD
  • Children planning to change (start or stop) psychotropic medication
  • Children who have changed a regimen of psychotropic medication (started or stopped) within 30 days prior to screening

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • HALP Clinic, Children's Center at Langley Porter, UCSF

    San Francisco, California, 94143

  • University of California San Francisco

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Web-based Professional Development for School Mental Health Providers in Evidence-Based Practices for Attention and Behavior Challenges

This study develops a web-based PD (CLS-R) to provide SSWs with remote training in EBPs for attention and behavior problems. CLS-R is designed to be usable, feasible, portable, accessible, and acceptable - ingredients which have been identified as necessary for the sustainability of school-based programs. The study evaluates the usability, feasibility, acceptability, fidelity of implementation, and preliminary effects on student outcomes.

Read the detailed description
  1. Title of Project: Web-Based Professional Development for School Mental Health Providers in Evidence-Based Practices for Attention and Behavior Challenges
  2. RFA Topic and Goal: Social and Behavioral Context for Academic Learning, Goal 2
  3. Purpose: Development of a web-based professional development program (PD) for school mental health providers to gain the skills needed to implement evidence-based practices (EBPs) for attention and behavior problems.
  4. Setting: The research will be conducted in elementary schools within San Francisco Unified School District (SFUSD).
  5. Sample: Participants will include SFUSD school social workers (SSWs), students, parents and teachers.
  6. Professional Development to be developed: The Collaborative Life Skills (CLS) program will be developed into a web-based format (CLS-R) with all training and consultation provided remotely via videoconferencing. Includes EBP skill modules for consulting with teachers and parents and working with students directly.
  7. Control Condition: N/A
  8. Research design and methods: (1)Open Trials and Refinement: CLS-R will be field tested with 4 SSWs delivering the intervention to students, parents, and teachers. Modification and refinement of materials, manuals, and procedures will follow each trial based on questionnaire data and focus groups. Outcomes will evaluate usability, feasability, and acceptability, implementation fidelity, preliminary effects on student outcomes, and post-training sustainability of SSW EBP skill use. (2) Pilot Study: Using a randomized design, we will compare CLS-R and CLS. Six SSWs will receive CLS-R and 6 SSWs will receive CLS. To temporarily conduct study during COVID-19 school closures, we will test feasbility, usability and accesptability of the fully remote CLS parent component.
  9. Key measures: Measures of process (training fidelity, attendance), feasibility, usability, and acceptability will be obtained.
  10. Data analytic strategy: CLS-R usability and feasibility will focus on qualitative analysis of themes from focus groups, quantitative analyses of rating scales, and descriptive analyses of functionality.
Conditions
ADHD
Being tested
CLS-R
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CLS-RBehavioural

    CLS-R Training includes school provider training in CLS via web platform and videoconferencing for workshops, consultation and coaching.CLS is a 10-12 week program and includes school, parent, and student components which are integrated via joint teacher, parent, and student meetings and use of integrated behavioral programs in the classroom and home.

Study groups in NCT05713331
Study groupRoleWhat they receive
CLS-RExperimentalWeb-based remote training for school mental health providers
Receives: Behavioral: CLS-R
CLSActive comparatorIn-person training for school mental health providers
Receives: Behavioral: CLS-R

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms of Attention Deficit Hyperactivity Disorder as defined by DSMV

    Parent and teacher rating scale

    Measured: Change from baseline to post-treatment

Secondary outcomes (8)
  1. Homework Problems Checklist (HPC)

    Parent-rated scale

    Measured: Change from baseline to post-treatment

  2. Children's Organizational Skills Scale (COSS)

    Parent and teacher rating scale

    Measured: Change from baseline to post-treatment

  3. Symptoms of Oppositional Defiant Disorder as defined by DSMV

    Parent and teacher rating scale

    Measured: Change from baseline to post-treatment

  4. Strengths and Difficulties Questionnaire

    Parent and teacher rating scale

    Measured: Change from baseline to post-treatment

  5. Clinical Global Improvement

    Parent and teacher rating scale

    Measured: Change from baseline to post-treatment

  6. School Mental Health Provider Rating of Skill Competence, Motivation and Knowledge

    School mental health provider rating scale

    Measured: Change from baseline to post-treatment

  7. Alabama Parenting Questionnaire

    Parent rating scale

    Measured: Change from baseline to post-treatment

  8. Parenting Stress Index

    Parent rating scale

    Measured: Change from baseline to post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study start1 Sep 2017
  3. Primary completion30 Jun 2020
  4. Study completion30 Jun 2020

Why it stopped: School closures during COVID-19 precluded study activities

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
79 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05713331
Sponsor's protocol ID
R305A170338
Acronym
CLS-R
Status last verified
Jan 2023
First submitted
31 Oct 2022
Last updated
6 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chung S, Lai J, Hawkey EJ, Dvorsky MR, Owens E, Huston E, Pfiffner LJ. Feasibility study of a telehealth school-based behavioral parent training group program for attention-deficit/hyperactivity disorder. J Pediatr Psychol. 2024 Oct 1;49(10):700-709. doi: 10.1093/jpepsy/jsae060.

    PubMed 39186568

Questions about this trial

What is this clinical trial studying?

A study testing CLS-R in people with ADHD, run by University of California, San Francisco at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: School closures during COVID-19 precluded study activities). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms of Attention Deficit Hyperactivity Disorder as defined by DSMV (time frame: Change from baseline to post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05713331, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
CLS-R Clinical Trial NCT05713331 | AzTrials